Stena Pharm SRL
Stena Pharm reported total assets of 301,170 € at the end of the 2025 financial year (annual accounts filed with the NBB on 20 Jul 2026).
The score of Stena Pharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -12 % Total assets -15 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Stena Pharm's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −5,903 € | ||||
| Equity | 252,466 € | ||||
| Cash | 142,115 € | ||||
| EBITDA | 14,867 € | ||||
| Total assets | 301,170 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Jul 2026
- Year ended 31 Dec 2024filed on 29 Jul 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
- Year ended 31 Dec 2022filed on 29 Jul 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Stena Pharm's financial analysis
- Solvency83.8%sector median: 58.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Stena Pharm
Stena Pharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0834.256.121
- VAT number
- BE0834256121
- Peppol
- Registered · 0208:0834256121 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Mar 2011
- Registered office
- 2180 Antwerp
- Latest accounts
- 2025 · filed on 20 Jul 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Stena Pharm (SRL) has been based in Antwerp since 2011, active in: business and other management consultancy activities. For 2025, it reports a net loss of 5,903 € and equity of 252,466 €; its revenue is not published. Its solvency stands at 83.8%, above the median of its sector (58.9%).
Companies similar to Stena Pharm
Companies in the same business, of comparable size and area, outside its group.
- Oud Gelaeg Business and other management consultancy activities Temse · balance sheet 301,147 €
- Belcotra Business and other management consultancy activities Kruisem · balance sheet 301,663 €
- Cuidado Business and other management consultancy activities Boortmeerbeek · balance sheet 301,689 €
- Quasarex Business and other management consultancy activities Halle · balance sheet 301,819 €
- Baticore Business and other management consultancy activities Soumagne · balance sheet 300,480 €
- Heyla Business and other management consultancy activities Ghent · balance sheet 301,955 €
- JABE Business and other management consultancy activities Dilsen-Stokkem · balance sheet 302,632 €
- DB Insights Business and other management consultancy activities Braine-l'Alleud · balance sheet 299,413 €
Frequently asked questions about Stena Pharm
What is the revenue of Stena Pharm?
Stena Pharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Stena Pharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0834256121 for Stena Pharm, if the company is VAT-registered. Its company number (CBE) is 0834.256.121.
Where is the registered office of Stena Pharm?
According to the CBE register, the registered office of Stena Pharm is in 2180 Antwerp.
What is the equity of Stena Pharm?
At the close of the 2025 financial year, the equity of Stena Pharm amounts to 252,466 €, a solvency of 83.8% of total assets.
Who manages Stena Pharm?
The register lists 2 active mandates at Stena Pharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Stena Pharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →